MESENCHYMAL CHONDROSARCOMA
Clinical trials for MESENCHYMAL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MESENCHYMAL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for MESENCHYMAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for rare sarcomas
Disease control OngoingThis study tests whether adding the drug pazopanib to standard radiation or chemoradiation helps shrink soft tissue sarcomas before surgery. About 140 patients with newly diagnosed, removable tumors took part. The goal is to see if the combination is safe and improves tumor respo…
Matched conditions: MESENCHYMAL CHONDROSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Could a targeted drug halt rare bone cancer?
Disease control OngoingThis study tested a drug called vismodegib in 45 people with advanced chondrosarcoma, a rare bone cancer that has spread and is hard to treat. The goal was to see if the drug could shrink tumors or stop them from growing for at least 6 months. While not a cure, the approach aims …
Matched conditions: MESENCHYMAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:47 UTC